DSM-Firmenich plans to separate animal nutrition and health business amid rising vitamin price volatility.
DSM-Firmenich shares rose after the company reported market-beating earnings and announced plans to separate its animal nutrition and health business. The company believes that the full potential of the ANH business could be realized through a different ownership structure, with all potential separation options being considered. The separation aims to reduce exposure to vitamins earnings volatility and capital intensity following unprecedented cyclical pressure on vitamin prices in the animal markets.
14 months ago
10 Articles
You have 7 free stories remaining this month. Subscribe anytime for unlimited access.